Pharma rings the changes as CEO shake-up continues [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
Chaplin, who has been at the helm of the Danish vaccine specialist since 2014, is leaving for personal reasons. Over his tenure, he has overseen Bavarian's development from a small research-based company to a publicly listed vaccine manufacturer with approved products in multiple regions. Chaplin will continue to serve as CEO for the remainder of 2026, unless a successor is identified earlier. The company's board is currently initiating a search for a new CEO. The outgoing exec said in a statement: “We have achieved a lot and created a strong foundation for the future of the company. My family wants to relocate back to Australia, but I remain fully committed to the company for the remainder of the year to allow for a stable transition to its next CEO.” The departure of Chaplin marks the latest in a recent shakeup at pharmaceutical companies. Doug Ingram revealed last month that he will leave rare disease biopharma Sarepta. After a decade overseeing the development of therapies
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Amgen Faces Rocatinlimab Halt And Rethinks Pipeline And Capital Priorities [Yahoo! Finance]Yahoo! Finance
- Podcast: Sanofi's head of clinical supply chain operations on evolving the clinical trial supply model [Yahoo! Finance]Yahoo! Finance
- Avalyn Appoints Biopharmaceutical Industry Leader Kate Haviland to Board of Directors [Yahoo! Finance]Yahoo! Finance
- Press Release: Sanofi's Board of Directors proposes the appointment of Christel Heydemann as an independent director [Yahoo! Finance]Yahoo! Finance
- Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent directorGlobeNewswire
SNY
Sec Filings
- 3/4/26 - Form 6-K
- 3/3/26 - Form 6-K
- 2/23/26 - Form 6-K
- SNY's page on the SEC website